Claus Michael Rödel

机构：Goethe University Frankfurt, German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, University Hospital Frankfurt, Frankfurt Cancer Institute · ORCID：0000-0001-7409-7093

发表论文 579 篇 · 总被引 24870 次 · h-index 65

代表论文

• ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors (2025 · Annals of Oncology · 被引 20)
• Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy (2023 · European Journal of Cancer · 被引 20)
• De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status—results of a prospective multicenter phase II trial (DIREKHT Trial) (2024 · Frontiers in Oncology · 被引 16)
• Overall Survival After Treatment Failure Among Patients With Rectal Cancer (2023 · JAMA Network Open · 被引 14)
• Preoperative Treatment of Locally Advanced Rectal Cancer (2023 · New England Journal of Medicine · 被引 13)
• Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma (2024 · npj Precision Oncology · 被引 9)